Closing the ethics gap in research PPPs: a role for translational science and proximal ethicality - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Closing the ethics gap in research PPPs: a role for translational science and proximal ethicality

Description:

Closing the ethics gap in research PPPs: a role for translational science and ... The Ethics Gap. Business ethics. Commercial values. Public. Organizations ... Working definition ... – PowerPoint PPT presentation

Number of Views:359
Avg rating:3.0/5.0
Slides: 27
Provided by: cihri
Category:

less

Transcript and Presenter's Notes

Title: Closing the ethics gap in research PPPs: a role for translational science and proximal ethicality


1
Closing the ethics gap in research PPPsa role
for translational science and proximal
ethicality?
Janet Atkinson-Grosjean, PhD Senior Research
Associate W. Maurice Young Centre for Applied
EthicsUniversity of British Columbia
2
Overview
  • The new research order
  • An ethics gap opens
  • Proximal ethicality as a bridge?
  • The translational genomics study
  • Checklists and recommendations

3
1. The new research order
4
Linear model of research(the golden age)
Public
Basic Research
Applied RD
Production
State
Academy

Market
Industry
PUBLIC
PRIVATE
Growth
Taxes
Public/Private Divide
5
The new nonlinear research order (the messy
reality)
Public-private divide is open and permeable
Research Councils
Big Pharma
Academy

Industry CanadaHealth Canadaetc
Hybrid or boundary organizations
Biotech
The Public Interest
Source JAG 2006
6
Formal and informal boundary hybrids
7
Hybrid organizations and translational science
Hybrid Organizations
Academy
Industry
PureBasic
TranslationalScience
PureApplied
Edison
Bohr
Pasteur
Translational science is use-inspired1Translati
on-to-profit (commercial)Translation-to-practice
(clinical/practical)Public-interest-translation
(civic/social)
1. Stokes (1997)
8
2. An ethics gap opens
9
An Ethics Gap
PublicOrganizations
Private Organizations
Hybrid Organizations
Public sector ethicsDemocratic values
The Ethics Gap
Business ethicsCommercial values
Largely due to their novelty, an ethics gap opens
up in hybrid organizations and translational
science
10
Comparing value domains
Sources Denhardt 2003, Gawthrop 1984
11
Where do hybrids fit?
12
3. Proximal ethicality as a bridge?
13
How we learn proximal development
  • Lev Vygotsky childhood development
  • Basic concept applied more broadly
  • we learn best when taught by more experienced
    others within our communities of practice
  • An apprenticeship model sitting by Nelly
  • Novices learn from Masters

14
Communities of practice
Source Hakkarainen 2004
15
Proximal ethicality
  • Working definition
  • The co-production of ethical understanding in new
    public-private communities of practice where each
    is a novice in the ethical domain of the other
    and all are engaged in translational science

16
4. The Translational Genomics Study
17
Three domains of translational science
  • Our typology
  • Translation to practice
  • Functional domain
  • Clinical science
  • Translation to profit
  • Commercial domain
  • Merchant science
  • Translation in the public interest
  • Societal domain
  • Civic science

18
Translational genomics
  • Working definition
  • Any activity that tends to move genomics out of
    the laboratory, and into the market, the clinic,
    or society at large

19
Rationale for the study
  • Little research available on translational
    science and scientists who translate
  • Translational requirements are pervasive in
    funding agreements but results often fall short
    of expectations
  • Translational science often conducted under
    hybrid arrangements that lack clear ethical
    guidelines
  • Goal 1 fill the conceptual and empirical gaps in
    our understanding of translational science
  • Goal 2 bridge the ethics gap by developing
    understanding of how public and private cultures
    come together in translational science
  • Goal 3 construct policy-relevant ethical
    guidelines for scientists and funders engaged in
    translational science through hybrid
    organizations

20
Research methods
  • Comparative case studies of nodes in Genome
    Canadas Pathogenomics of Innate Immunity network
  • mixed methods of data collection (ie both
    qualitative and quantitative)
  • nested levels of analysis.
  • Individual scientists (120-150)
  • Laboratories (15-20)
  • Funding/ governance organizations (7-10)
  • Policy instruments and institutions (Canada, UK,
    Singapore, Ireland)
  • National and global political economic contexts

21
Factors to be examined
Fieldwork surveyssite visitsinterviews
  • 1. Individual preferences
  • 2. Community values
  • 3. Generational effects
  • 4. Organizational structures
  • 5. Policy institutions
  • 6. Political-economic contexts
  • 7. Others that arise

Conceptual studies and Literature reviews
22
5. Checklists and recommendations
23
PPPs and hybrid agencies an ethics checklist
  • What degree of political scrutiny and disclosure?
  • direct ministerial responsibility to Parliament?
  • What degree of financial scrutiny and disclosure?
  • subject to normal mechanisms of public-service
    oversight?
  • What degree of public scrutiny and disclosure?
  • obligation to report performance to the general
    public?
  • transparent mechanisms for external complaints
    and redress?
  • What degree of compliance with institutional
    checks and balances?
  • subject to Freedom of Information Act?
  • subject to scrutiny by Auditor General?

24
Questions for further discussion
  • What is the problem that PPPs and other hybrid
    agencies were established to address?
  • In what ways do PPPs and other hybrid agencies
    add value to the research enterprise?
  • Are PPPs a novel and productive convergence of
    public and private interests? Or, are they an
    ideologically driven policy reform? Are the two
    mutually exclusive?

25
Ethical questions, continued
  • What are the broader implications of delegating
    implementation, governance, and funding of
    national research efforts to privatized
    research partnerships?
  • Given the sums and interests involved, do PPPs
    provide adequate governance accountability?
  • What incentive is there for private partners to
    accept public-sector governance accountability
    structures?

26
Thanks to my colleagues and sponsors at W.
Maurice Young Centre for Applied Ethics
(UBC)Pathogenomics of Innate Immunity Network
Genome British ColumbiaGenome Canada
Write a Comment
User Comments (0)
About PowerShow.com